Default: Pharmacology and Therapeutics

ISSN: 0163-7258

Journal Home

Journal Guideline

Pharmacology and Therapeutics Q1 Unclaimed

Elsevier Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pharmacology and Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 201. It has an SJR impact factor of 3,461 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,461.

Pharmacology and Therapeutics focuses its scope in these topics and keywords: therapeutic, cancer, biology, actions, diseasethe, molecular, pharmacology, drug, clinical, dependence, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Pharmacology and Therapeutics

3,461

SJR Impact factor

201

H Index

162

Total Docs (Last Year)

450

Total Docs (3 years)

33410

Total Refs

5374

Total Cites (3 years)

450

Citable Docs (3 years)

11,45

Cites/Doc (2 years)

206,23

Ref/Doc

Aims and Scope


therapeutic, cancer, biology, actions, diseasethe, molecular, pharmacology, drug, clinical, dependence, compounds, drugsemerging, drugspharmacogenomics, drugsstable, dysregulation, effects, epigenomes, chemotherapeuticsthe, cells, cascade, antibodies, anticancer, antidepressant, antimalarialnew, garlictargeting, apelin, approach, aspects, autoimmune, brain, breast, bristolmyers,



Best articles by citations

Prostanoids and reactive oxygen species: Team players in endothelium-dependent contractions

View more

Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance

View more

PHARMACOLOGY & THERAPEUTICS

View more

Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine

View more

The regulation of nerve growth factor synthesis and delivery to peripheral neurons

View more

Market structure and conduct in the pharmaceutical industry

View more

The use of heterologously expressed drug metabolizing enzymes - state of the art and prospects for the future

View more

Ethanol regulation of gamma-aminobutyric acidA receptors: genomic and nongenomic mechanisms

View more

Potassium-competitive acid blockade: A new therapeutic strategy in acid-related diseases

View more

Modification of alternative splicing pathways as a potential approach to chemotherapy

View more

Drug targeting via retrometabolic approaches

View more

Clinical benefits and pharmacology of scutellarin: A comprehensive review

View more
SHOW MORE ARTICLES

Cytochrome P450-catalyzed pathways in human brain: Metabolism meets pharmacology or old drugs with new mechanism of action?

View more

Role of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones

View more

Structure-activity relationships among guanine-quadruplex telomerase inhibitors

View more

Antimalarial activity of synthetic analogues of distamycin

View more

Preface

View more

The dynamics of drug resistance in Plasmodium falciparum

View more

Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions

View more

Selective activation of E-type prostanoid3-receptors reduces myocardial infarct size

View more

Antitoxic immunity in cholera and enterotoxigenic escherichia coli (ETEC) diarrhea

View more

Adverse effects of established and new antiepileptic drugs: An attempted comparison

View more

Methyltransferase pharmacogenetics

View more

The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention

View more

Comments

No comments ... Be the first to comment!

FAQS